Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Post-COVID cognitive dysfunction: current status and research recommendations for high risk population
Meina Quan, Xuechu Wang, Min Gong, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100836-100836
Open Access | Times Cited: 57
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
Afaf El‐Malah, Magdy M. Gineinah, Pran Kishore Deb, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 827-827
Open Access | Times Cited: 45
Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19
Mario Gietl, Francesco Burkert, Stefanie Seiwald, et al.
International Journal of Tryptophan Research (2023) Vol. 16
Open Access | Times Cited: 17
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19
Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 30
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production
Naomi Oka, Kazuya Shimada, Azusa Ishii, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106954-106954
Open Access | Times Cited: 10
Bystander activation of microglia by Brucella abortus-infected astrocytes induces neuronal death via IL-6 trans-signaling
Julia Rodríguez, Julia De Santis Arévalo, Vida A. Dennis, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Mitophagy in the aging nervous system
Anna Rappe, Thomas G. McWilliams
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 17
Post-covid-19 neurological syndromes
В. В. Белопасов, Ekaterina N. Zhuravleva, Natalia P. Nugmanova, et al.
Journal of clinical practice (2021) Vol. 12, Iss. 2, pp. 69-82
Open Access | Times Cited: 21
An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)
Pasquale Pagliano, Carmine Sellitto, Giuliana Scarpati, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 1, pp. 9-18
Open Access | Times Cited: 18
Development of New Mental and Physical Health Sequelae among US Veterans after COVID-19
Nilang Patel, Bassam Dahman, Jasmohan S. Bajaj
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3390-3390
Open Access | Times Cited: 10
SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome
Josef Finsterer, Daniel Matovu, Fúlvio A. Scorza
Clinics (2022) Vol. 77, pp. 100064-100064
Open Access | Times Cited: 10
Identification of Coronary Artery Disease using Extra Tree Classification
Nazia Wahid, Abdelhamid Zaïdi, Gaurav Dhiman, et al.
2022 International Conference on Inventive Computation Technologies (ICICT) (2023), pp. 787-792
Closed Access | Times Cited: 5
Digital Orientation and Manufacturing Firms’ Green Innovation Performance: The Mediating Role of Green Competence
Courage Simon Kofi Dogbe, Nyankomo Marwa
Journal of risk and financial management (2024) Vol. 17, Iss. 10, pp. 430-430
Open Access | Times Cited: 1
A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system
Yu Zhang, Wei Deng, Min‐Jian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
HDAC Inhibition as Neuroprotection in COVID-19 Infection
Yudibeth Sixto‐López, José Correa‐Basurto
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 16, pp. 1369-1378
Closed Access | Times Cited: 8
Nervous system manifestations related to COVID-19 and their possible mechanisms
Zhen Xie, Hui Hao, Zhihan Zhao, et al.
Brain Research Bulletin (2022) Vol. 187, pp. 63-74
Open Access | Times Cited: 8
Drug-drug interactions between COVID-19 drug therapies and antidepressants
Efstathia Davoutis, C Panou, Nikolina Stachika, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 937-950
Closed Access | Times Cited: 3
Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implications
Akash Kumar, Ankita Chattopadhyay, Snehil Gupta
Asian Journal of Psychiatry (2022) Vol. 73, pp. 103101-103101
Open Access | Times Cited: 5
Heterocyclic compounds as antimicrobial agents
Pobitra Borah, Sangeeta Hazarika, Ashna Chettri, et al.
Elsevier eBooks (2023), pp. 781-804
Closed Access | Times Cited: 2
Antiviral drugs and vaccines
Pobitra Borah, Sangeeta Hazarika, Mohamed A. Morsy, et al.
Elsevier eBooks (2023), pp. 319-359
Closed Access | Times Cited: 2
A Consistent Deep Neural Network to Diagnose Heart Disease
M. Vijay Sekhar Babu, Anuradha Jha, Mukesh Soni, et al.
2022 International Conference on Inventive Computation Technologies (ICICT) (2023), pp. 370-375
Closed Access | Times Cited: 2
Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report
Onur Gökçen, Merve Akkuş
Turkish Journal of Psychiatry (2023)
Open Access | Times Cited: 2
The “Tipping Point” : When Electroencephalography (EEG), Quantitative EEG (QEEG) and Standardized Low Resolution Brain Electromagnetic Tomography (sLORETA) in COVID Went From “Ceasure” To “Non- Priority” To “First-Line” Tool in Triage, Diagnosis, Monitoring and Therapy
Priya Miranda, Slav Danev, Michael P. Alexander, et al.
Neurology and Neuroscience (2024) Vol. 5, Iss. 1
Open Access
Treatments for Medication-Induced Movement Disorders
Shih‐Ku Lin
Springer eBooks (2024), pp. 4445-4456
Closed Access
SARS-CoV-2 Protease Inhibitors of Natural Origin: Current Scenario and Future Prospects as Anti-COVID-19 Agents
Nikita Reddy, A. Srinivasa Rao, Dr Bethanapalli Mounika Mounika, et al.
Frontiers in Drug Design & Discovery (2024), pp. 175-225
Closed Access
Page 1 - Next Page

Scroll to top